Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Meglumine
1. 1-deoxy-1-(methylamino)hexitol
2. 6-(methylamino)hexane-1,2,3,4,5-pentol
3. D-(-)-n-methylglucamine
4. 90191-92-7
5. N-methyl-d-glucamine, 99%
6. (2r,3r,4r,5s)-6-methylaminohexane-1,2,3,4,5-pentol
7. Smr000387082
8. Nsc 7391
9. Nsc52907
10. Nsc 52907
11. N-methylglycamine
12. Glucitol, 1-deoxy-1-(methylamino)-, D-
13. 6-(methylamino)hexane-1,2,3,4,5-pentaol
14. Prestwick0_000884
15. Prestwick1_000884
16. Prestwick2_000884
17. Prestwick3_000884
18. Schembl5584
19. Bspbio_000668
20. Mls001048885
21. Mls006011915
22. Spbio_002887
23. Bpbio1_000736
24. Chembl333195
25. Meglumine N-methyl-d-glucamine
26. Chebi:95217
27. Dtxsid70859264
28. Nsc7391
29. Hms1570b10
30. Hms2097b10
31. Hms2267b12
32. Hms3655b07
33. 1-deoxy-1-(methylamino)hexitol #
34. Bbl007602
35. Mfcd00066771
36. Stk801441
37. Akos005068279
38. 6-methylamino-1,2,3,4,5-hexanepentol
39. Ncgc00179482-01
40. 6-methylaminohexane-1,2,3,4,5-pentaol
41. Vs-01687
42. Db-055497
43. Ab00513945
44. Ft-0607695
45. Ft-0655868
46. Wurcs=2.0/1,1,0/[hxxxxh_1*nc]/1/
47. Ab00513945-08
48. Sr-01000758225
49. Q-201347
50. Sr-01000758225-2
51. Q27167037
| Molecular Weight | 195.21 g/mol |
|---|---|
| Molecular Formula | C7H17NO5 |
| XLogP3 | -2.8 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 6 |
| Exact Mass | 195.11067264 g/mol |
| Monoisotopic Mass | 195.11067264 g/mol |
| Topological Polar Surface Area | 113 Ų |
| Heavy Atom Count | 13 |
| Formal Charge | 0 |
| Complexity | 134 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 4 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Contrast Media
Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
46
PharmaCompass offers a list of Methylglucamine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Methylglucamine manufacturer or Methylglucamine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Methylglucamine manufacturer or Methylglucamine supplier.
PharmaCompass also assists you with knowing the Methylglucamine API Price utilized in the formulation of products. Methylglucamine API Price is not always fixed or binding as the Methylglucamine Price is obtained through a variety of data sources. The Methylglucamine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Methylglucamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Methylglucamine, including repackagers and relabelers. The FDA regulates Methylglucamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Methylglucamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Methylglucamine supplier is an individual or a company that provides Methylglucamine active pharmaceutical ingredient (API) or Methylglucamine finished formulations upon request. The Methylglucamine suppliers may include Methylglucamine API manufacturers, exporters, distributors and traders.
Methylglucamine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Methylglucamine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Methylglucamine GMP manufacturer or Methylglucamine GMP API supplier for your needs.
A Methylglucamine CoA (Certificate of Analysis) is a formal document that attests to Methylglucamine's compliance with Methylglucamine specifications and serves as a tool for batch-level quality control.
Methylglucamine CoA mostly includes findings from lab analyses of a specific batch. For each Methylglucamine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Methylglucamine may be tested according to a variety of international standards, such as European Pharmacopoeia (Methylglucamine EP), Methylglucamine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Methylglucamine USP).
